
Immunization remains one of the most cost-effective health interventions — but the environment for decision-making is rapidly changing.
Over the past year, reductions in donor funding have placed increasing pressure on countries to do more with less. At the same time, the space for evidence-based decision-making is becoming more fragile, especially in immunization, with growing risks that resource allocation decisions are not consistently guided by the best available data.
In this context, robust economic evidence to inform optimized resource allocation is more important than ever.
Immunization Economics exists to ensure that decisions about vaccination — what to fund, how to prioritize, and how to design programs — are grounded in robust evidence.
We connect researchers, policymakers, and practitioners across over 115 countries to ensure that economic evidence is produced and used to shape real-world decisions.
